Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Geranylgeranyl pyrophosphate synthase | 0 | 3 | 0 | 3 |
Farnesyl pyrophosphate synthase | 0 | 6 | 0 | 6 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
thioredoxin reductase | 3 | 0 | 0 | 3 |
GALC protein | 1 | 0 | 0 | 1 |
GLI family zinc finger 3 | 8 | 0 | 0 | 8 |
nuclear receptor subfamily 1, group I, member 3 | 3 | 0 | 0 | 3 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 6 | 0 | 0 | 6 |
glucocorticoid receptor [Homo sapiens] | 11 | 0 | 0 | 11 |
retinoic acid nuclear receptor alpha variant 1 | 8 | 0 | 0 | 8 |
retinoid X nuclear receptor alpha | 6 | 0 | 0 | 6 |
estrogen-related nuclear receptor alpha | 8 | 0 | 0 | 8 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
arylsulfatase A | 3 | 0 | 0 | 3 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
euchromatic histone-lysine N-methyltransferase 2 | 4 | 0 | 0 | 4 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 7 | 0 | 0 | 7 |
geminin | 5 | 0 | 0 | 5 |
peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 3 | 1 | 0 | 4 |
ATP-binding cassette sub-family C member 3 | 0 | 5 | 0 | 5 |
Multidrug resistance-associated protein 4 | 0 | 5 | 0 | 5 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 12 | 0 | 3 | 1 | 6 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
Bile salt export pump | 0 | 7 | 0 | 7 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Renin | 0 | 2 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 4 | 1 | 9 |
Carbonic anhydrase 2 | 0 | 4 | 1 | 8 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 3 | 1 | 6 |
Cathepsin B | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 2 | 0 | 2 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 2 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
Cytochrome P450 2A6 | 0 | 2 | 1 | 3 |
Cytochrome P450 2C9 | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 1 | 0 | 4 |
Translocator protein | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 3 | 1 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 1 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 1 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 1 | 0 | 4 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 3 | 1 | 5 |
Carbonic anhydrase 6 | 0 | 3 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 1 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 1 | 0 | 4 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 1 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 1 | 0 | 4 |
Endochitinase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 1 | 0 | 4 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 1 | 2 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 1 | 6 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 3 | 1 | 5 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 2 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 1 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 1 | 0 | 4 |
Cholinesterase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 3 | 0 | 3 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Squalene synthase | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 4 | 1 | 7 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase, alpha family | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 3 |
Carbonic anhydrase | 0 | 2 | 0 | 3 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 2 | 0 | 2 |
Delta carbonic anhydrase | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Endochitinase A1 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 3 | 1 | 5 |
GABA theta subunit | 3 | 1 | 0 | 4 |
Canalicular multispecific organic anion transporter 1 | 0 | 5 | 0 | 5 |
Carbonic anhydrase 4 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 15 | 0 | 2 | 0 | 3 |
Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 3 | 1 | 0 | 4 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 3 | 1 | 6 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 1 | 6 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
acetylcholinesterase | 3 | 0 | 0 | 3 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
pregnane X receptor | 5 | 0 | 0 | 5 |
phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
USP1 protein, partial | 2 | 0 | 0 | 2 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
Thrombopoietin | 2 | 0 | 0 | 2 |
AR protein | 8 | 0 | 0 | 8 |
regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
farnesoid X nuclear receptor | 3 | 0 | 0 | 3 |
estrogen nuclear receptor alpha | 10 | 0 | 0 | 10 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 4 | 0 | 0 | 4 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 4 | 0 | 0 | 4 |
heat shock protein beta-1 | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
Histone deacetylase 3 | 0 | 2 | 0 | 2 |
Histone deacetylase 4 | 0 | 2 | 0 | 2 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
Histone deacetylase 1 | 0 | 2 | 0 | 2 |
Histone deacetylase 7 | 0 | 2 | 0 | 2 |
Histone deacetylase 2 | 0 | 2 | 0 | 2 |
Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
Histone deacetylase 11 | 0 | 2 | 0 | 2 |
Ataxin-2 | 6 | 0 | 0 | 6 |
Histone deacetylase 8 | 0 | 2 | 0 | 2 |
Histone deacetylase 6 | 0 | 2 | 0 | 2 |
Histone deacetylase 9 | 0 | 2 | 0 | 2 |
Histone deacetylase 5 | 0 | 2 | 0 | 2 |
ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
Chain A, farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 2 | 0 | 2 |
Farnesyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
Farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
Integrin beta-3 | 0 | 1 | 0 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Integrin alpha-V | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 0 | 1 | 0 | 1 |
Integrin alpha-5 | 0 | 1 | 0 | 1 |
Integrin beta-5 | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 0 | 1 | 1 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 16 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 21 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
Chain A, Cruzipain | 2 | 0 | 0 | 2 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
glp-1 receptor, partial | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1 alpha subunit | 4 | 0 | 0 | 4 |
SMAD family member 2 | 2 | 0 | 0 | 2 |
PPM1D protein | 2 | 0 | 0 | 2 |
SMAD family member 3 | 2 | 0 | 0 | 2 |
TDP1 protein | 6 | 0 | 0 | 6 |
Smad3 | 1 | 0 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
progesterone receptor | 7 | 0 | 0 | 7 |
EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
pregnane X nuclear receptor | 6 | 0 | 0 | 6 |
G | 3 | 0 | 0 | 3 |
cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
67.9K protein | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
Rac1 protein | 0 | 0 | 1 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
IDH1 | 2 | 0 | 0 | 2 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 6 | 0 | 0 | 6 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
activating transcription factor 6 | 2 | 0 | 0 | 2 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 4 | 0 | 0 | 4 |
Histone H2A.x | 1 | 0 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
interferon gamma precursor | 0 | 0 | 0 | 1 |
prostaglandin E2 receptor EP2 subtype | 0 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 4 | 0 | 0 | 4 |
potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
lamin isoform A-delta10 | 3 | 0 | 0 | 3 |
Prostaglandin E synthase | 0 | 1 | 0 | 1 |
3-phosphoinositide-dependent protein kinase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 1 | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Interferon beta | 5 | 0 | 0 | 5 |
HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
Cellular tumor antigen p53 | 4 | 0 | 0 | 4 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Procathepsin L | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Quinolone resistance protein NorA | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Calpain-2 catalytic subunit | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
Glutamate receptor 2 | 3 | 0 | 0 | 3 |
D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Cruzipain | 0 | 1 | 0 | 1 |
Sodium/hydrogen exchanger 1 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 3 | 1 | 5 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Cyclooxygenase-2 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
ATPase family AAA domain-containing protein 5 | 5 | 0 | 0 | 5 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
GLS protein | 2 | 0 | 0 | 2 |
vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 2 | 3 | 0 | 0 | 3 |
interleukin 8 | 1 | 0 | 0 | 1 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
Neutral amino acid transporter A | 0 | 2 | 0 | 2 |
Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 2 | 0 | 2 |
Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 2 |
Amino acid transporter | 0 | 2 | 0 | 2 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
Chymotrypsinogen A | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 0 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Atrial natriuretic peptide receptor 3 | 0 | 1 | 0 | 1 |
Thromboxane A2 receptor | 0 | 1 | 0 | 2 |
Type-1A angiotensin II receptor | 0 | 2 | 1 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
Type-1 angiotensin II receptor | 0 | 2 | 1 | 5 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
Type-2 angiotensin II receptor | 0 | 1 | 0 | 1 |
Spike glycoprotein | 3 | 0 | 0 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
Platelet glycoprotein VI | 0 | 1 | 1 | 3 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
nonstructural protein 1 | 2 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Glucocorticoid receptor | 0 | 6 | 2 | 13 |
Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 2 | 3 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor DM1 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 2 | 0 | 0 | 2 |
Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
luciferase | 0 | 0 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Histamine H1 receptor | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 2 | 0 | 0 | 2 |
Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Pyruvate kinase PKM | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 1 | 2 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |